HL Financial Services LLC reduced its stake in shares of Masimo Co. (NASDAQ:MASI) by 3.3% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 42,676 shares of the medical equipment provider’s stock after selling 1,477 shares during the period. HL Financial Services LLC’s holdings in Masimo were worth $4,582,000 at the end of the most recent reporting period.
Several other hedge funds also recently bought and sold shares of the company. FMR LLC lifted its holdings in Masimo by 6,605.4% in the 2nd quarter. FMR LLC now owns 1,821,994 shares of the medical equipment provider’s stock worth $177,918,000 after purchasing an additional 1,794,822 shares in the last quarter. BlackRock Inc. lifted its holdings in Masimo by 23.1% in the 3rd quarter. BlackRock Inc. now owns 8,311,900 shares of the medical equipment provider’s stock worth $1,035,164,000 after purchasing an additional 1,562,019 shares in the last quarter. American Century Companies Inc. lifted its holdings in Masimo by 932.6% in the 3rd quarter. American Century Companies Inc. now owns 850,436 shares of the medical equipment provider’s stock worth $105,913,000 after purchasing an additional 768,078 shares in the last quarter. Marshall Wace LLP lifted its holdings in Masimo by 199.4% in the 3rd quarter. Marshall Wace LLP now owns 554,025 shares of the medical equipment provider’s stock worth $68,998,000 after purchasing an additional 368,958 shares in the last quarter. Finally, Ownership Capital B.V. purchased a new position in Masimo in the 3rd quarter worth approximately $39,259,000. 87.36% of the stock is currently owned by hedge funds and other institutional investors.
NASDAQ:MASI opened at $129.62 on Tuesday. Masimo Co. has a 1 year low of $81.56 and a 1 year high of $130.00. The company has a market capitalization of $6.87 billion, a price-to-earnings ratio of 52.91, a PEG ratio of 2.73 and a beta of 1.07.
A number of research analysts recently commented on MASI shares. BidaskClub cut Masimo from a “strong-buy” rating to a “buy” rating in a report on Saturday, November 3rd. UBS Group started coverage on Masimo in a report on Tuesday, November 27th. They issued a “buy” rating and a $137.00 price target on the stock. Zacks Investment Research raised Masimo from a “hold” rating to a “buy” rating and set a $115.00 price target on the stock in a report on Monday, November 26th. Needham & Company LLC reissued a “buy” rating and issued a $139.00 price target on shares of Masimo in a report on Friday, February 1st. Finally, Piper Jaffray Companies boosted their price target on Masimo to $120.00 and gave the stock a “neutral” rating in a report on Thursday, November 1st. One analyst has rated the stock with a hold rating, seven have issued a buy rating and one has issued a strong buy rating to the stock. Masimo currently has a consensus rating of “Buy” and an average target price of $121.86.
ILLEGAL ACTIVITY WARNING: This piece of content was posted by Chaffey Breeze and is owned by of Chaffey Breeze. If you are reading this piece of content on another site, it was illegally stolen and republished in violation of United States & international copyright and trademark laws. The legal version of this piece of content can be read at https://www.chaffeybreeze.com/2019/02/19/hl-financial-services-llc-has-4-58-million-stake-in-masimo-co-masi.html.
Masimo Company Profile
Masimo Corporation, a medical technology company, develops, manufactures, and markets noninvasive monitoring technologies worldwide. The company offers Masimo Signal Extraction Technology (SET) pulse oximetry with measure-through-motion and low-perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry.
Want to see what other hedge funds are holding MASI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Masimo Co. (NASDAQ:MASI).
Receive News & Ratings for Masimo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Masimo and related companies with MarketBeat.com's FREE daily email newsletter.